Loading chat...

PA HB377

Bill

Status

Introduced

1/28/2025

Primary Sponsor

Andrew Kuzma

Click for details

Origin

House of Representatives

2025-2026 Regular Session

AI Summary

  • Prohibits the manufacture, delivery, or possession with intent to manufacture or deliver tianeptine (including any salt, compound, derivative, or preparation) by unregistered persons or unlicensed practitioners in Pennsylvania

  • Classifies violations as a felony punishable by up to 5 years imprisonment, a fine up to $15,000, or both

  • Amends The Controlled Substance, Drug, Device and Cosmetic Act of 1972 by adding tianeptine restrictions as clause (41) under prohibited acts

  • Takes effect immediately upon enactment

Legislative Description

Further providing for prohibited acts and penalties.

Last Action

Laid on the table

9/10/2025

Committee Referrals

Rules6/30/2025
Judiciary1/28/2025

Full Bill Text

No bill text available